Publications by authors named "Yuping Gong"

Claim this Profile
T
Targeted therapy in KMT2Ar AML.
Ying Zhang, Yankun Yang, Yiwen Du, Yuqian Tang, Yuping Gong

Hematology· December 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF3R Mutations Imply Adverse Prognostic Impact in Adult Acute Myeloid Leukemia Patients: A Single-Center Retrospective Study.
Jinjun Yang, Lian Wang, Min Zhu, Xinrong Xiang, Yu Wu, Yuping Gong

Cancer Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax plus decitabine, cytarabine, aclarubicin, and G-CSF in adults with newly diagnosed acute myeloid leukemia: A multicenter, retrospective study.
Ying Zhang, Kun Yang, Yong Guo, Jin Rao, Feng Wang, Yuping Gong

Int J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Ferroptosis-associated pathological injury mechanisms and therapeutic strategies after intracerebral hemorrhage.
Yuhua Gong, Fumei Yang, Ying Liu, Yuping Gong

Front Neurol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
METTL3, an Independent Adverse Prognostic Factor for AML, Promotes the Development of AML by Modulating the PGC-1α-MAPK Pathway and PGC-1α-Antioxidant System Axis.
Yuqian Tang, Xiaoyan Liu, Wu Ye, Xiaojia Wang, Xiaoyu Wei, Yuping Gong

Cancer Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Role of Red Blood Cell Lifespan in Transfusion-Dependent β-Thalassemia and Impact of Thalidomide Treatment.
Kun Yang, Yuping Gong, Jian Xiao

Am J Hematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Rare t(X;21)(p11;q22) in Childhood Acute Myeloid Leukemia: Case Report and Literature Review.
Yiwen Du, Kun Yang, Yuqian Tang, Ruixia Fan, Yuping Gong

Pediatr Blood Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microglial Mechanisms and Therapeutic Potential in Brain Injury Post-Intracerebral Hemorrhage.
Yuhua Gong, Hui Li, Huanglin Cui, Yuping Gong

J Inflamm Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case report of acute promyelocytic leukemia with myeloid sarcoma of the lumbar spine and literature review.
Yiwen Du, Kun Yang, Yantao Ling, Ying Zhang, Yuping Gong

Front Med (Lausanne)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax plus D-CAG (decitabine, cytarabine, aclarubicin, G-CSF) for elderly or unfit patients with newly diagnosed acute myeloid leukemia: a multicenter, prospective study.
Hongbing Ma, Yiwen Du, Jianjun Li, Jin Rao, Yong Guo, Yuping Gong

Ann Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard dose anthracycline plus all-trans retinoic acid and arsenic trioxide as induction chemotherapy significantly reduces early death and relapse for high-risk acute promyelocytic leukemia: a single-center real-world analysis.
Kai Shen, Jie Huang, Chenlu Yang, Xiao Shuai, Yong Guo, Yuping Gong

Ther Adv Hematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia.
Xia Wu, Fangfang Wang, Xijing Yang, Yuping Gong, Ting Niu

Small· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study.
Yu Hu, Xiaofan Liu, Hu Zhou, Shujie Wang, Ruibin Huang, Yuping Gong

Lancet Haematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 vaccination in splenectomized patients with immune thrombocytopenia-Response.
Xiang Liu, Xinai Gan, Jing Xu, Yutong Wang, Jie Huang, Yuping Gong

Br J Haematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ivosidenib in Chinese patients with relapsed or refractory isocitrate dehydrogenase 1 mutated acute myeloid leukemia: a registry study.
Mingyuan Sun, Qingsong Yin, Yang Liang, Chunkang Chang, Jing Zheng, Yuping Gong

Blood Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective effects of COVID-19 vaccination in splenectomized patients with immune thrombocytopenia.
Xiang Liu, Xinai Gan, Jing Xu, Yutong Wang, Jie Huang, Yuping Gong

Br J Haematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 study.
Min Xu, Jinhui Shu, Shenxian Qian, Jingming Guo, Yuping Gong

Lancet Reg Health West Pac· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study.
Lei Zhao, Jinjun Yang, Mengran Chen, Xinrong Xiang, Hongbing Ma, Yuping Gong

Ann Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib-based frontline therapy followed by ixazomib maintenance in frail elderly newly diagnosed with multiple myeloma: a prospective multicenter study.
Li Bao, Yu-Tong Wang, Peng Liu, Min-Qiu Lu, Jun-Ling Zhuang, Yu-Ping Gong

EClinicalMedicine· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis and risk factors for ASXL1 mutations in patients with newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.
Liqing Yang, Xiaoyu Wei, Yuping Gong

Cancer Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical features and prognostic implications of PTPN11 mutation in adult patients with acute myeloid leukemia in China.
Jinjun Yang, Lei Zhao, Yu Wu, Ting Niu, Yuping Gong

Cancer Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influencing factors of cancer-related fatigue in acute leukemia patients: A cross-sectional study.
Yingli Wang, Xinwen Du, Yuping Gong, Yan Jiang, Yuhuan Zheng

Heliyon· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL).
Guang Lu, Shikai Jin, Suwen Lin, Yuping Gong, Liwen Zhang

Clin Epigenetics· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 study.
Xiaofan Liu, Hu Zhou, Yu Hu, Jie Yin, Junmin Li, Yuping Gong

Lancet Haematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of PTD in patients with acute myeloid leukaemia: a systematic review and meta-analysis.
Wu Ye, Mingzhu Ma, Xia Wu, Jili Deng, Xiaoyan Liu, Yuping Gong

BMJ Open· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis